Fanconi's anaemia and related bone marrow failure syndromes

British Medical Bulletin

Volumn 77-78, Issue 1, 2006, Pages 37-53

  Dokal, Inderjeet ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bone marrow failure; DNA repair; Dyskeratosis congenita; Fanconi's anaemia; Telomerase

Indexed keywords

ANABOLIC AGENT; BUSULFAN; BUTADIENE DIEPOXIDE; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; DEFERASIROX; DEFEROXAMINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN C; OXYMETHOLONE; PANCREAS ENZYME; PREDNISOLONE;

APLASTIC ANEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; BONE MARROW DEPRESSION; CHROMOSOME BREAKAGE; CLINICAL FEATURE; CYTOLOGY; DNA REPAIR; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HEMATOPOIESIS; HUMAN; IRRADIATION; MALABSORPTION; MOLECULAR BIOLOGY; NEUTROPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHWACHMAN SYNDROME; STEM CELL TRANSPLANTATION; TELOMERE; THALASSEMIA MAJOR;

ANEMIA, DIAMOND-BLACKFAN; BONE MARROW DISEASES; DNA DAMAGE; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; HUMANS; SYNDROME;

EID: 33846259705     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldl007     Document Type: Article

References (37)

1. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D (eds). Nathan and Oski's Hematology of Infancy and Childhood, 6th edn. Philadelphia, PA: WB Saunders, 2003,280-365.
2. Auerbach AD, Buchwald M, Joenje H. In: Scriver CR et al. (ed). The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 2001,753-68.
3. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia-clinical and molecular aspects. Br J Haematol 2004;126:176-91.
4. Levitus M, Rooimans MA, Steltenpool J et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 2004;103:2493-503.
5. Garcia-Higuera I, Taniguchi T, Ganesan S et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001;7:249-62.
6. Howlett NG, Taniguchi T, Olson S et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
7. Kennedy RD, D'Andrea AD. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev 2005;19:2925-40.
8. Guardiola P, Socie G, Pasquini R et al. Allogeneic stem cell transplantation for Fanconi anaemia. Bone Marrow Transplant 1998;21(Suppl. 2):24-7.
9. Guardiola Ph, Pasquini R, Dokal I et al. Outcome of 69 allogeneic stem transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000;95:422-9.
10. de la Fuente J, Reiss S, McCloy M et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003;32:653-6.
11. Motwani J, Lawson SE, Darbyshire PJ. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia-experience in a single UK centre. Bone Marrow Transplant 2005;36:405-10.
12. Liu JM, Kim S, Read EJ et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 1999;10:2337-46.
13. Waisfisz Q, Morgan NV, Savino M et al. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 1999;22:379-83.
14. Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med 2004; 6(26):1-23.
15. Connor JM, Gatherer D, Gray FC et al. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 1986;72:348-51.
16. Heiss NS, Knight SW, Vulliamy TJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19:32-8.
17. Knight SW, Heiss NS, Vulliamy TJ et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 1999;107:335-9.
18. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999;402:551-5.
19. Vulliamy T, Marrone A, Goldman F et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001;413:432-5.
20. Vulliamy T, Marrone A, Dokal I et al. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002;359:2168-70.
21. Yamaguchi H, Baerlocher GM, Lansdorp PM et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003;102:916-8.
22. Keith WN, Vulliamy T, Zhao J et al. A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with paroxysmal nocturnal haemoglobinuria. BMC Blood Disord 2004; 4:3-11.
23. Yamaguchi H, Calado RT, Ly H et al. Mutations in TERT, the gene for reverse transcriptase, in aplastic anemia. N Engl J Med 2005;352:1413-24.
24. Vulliamy T, Walne A, Baskaradas A et al. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 2005;34:257-63.
25. Armanios M, Chen JL, Chang YPC et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 2005;102:15960-4.
26. Shwachman H, Diamond LK, Oski FA, Khaw KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964;65:645- 63.
27. Bodian M, Sheldon W, Lightwood R. Congenital hypoplasia of the exocrine pancreas. Acta Paediatr 1964;53:282-93.
28. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol 2002;118:701-13.
29. Boocock GRB, Morrison JA, Popovic M et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33:97-101.
30. Shammas C, Menne TF, Hilcenko C et al. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman Diamond Syndrome. J Biol Chem 2005;13:19221-9.
31. Cesaro S, Oneto R, Messina C et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 2005;131:231- 6.
32. Lipton JM, Atsidaftos E, Zyskind I et al. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer 2006;46:558-64.
33. Giri N, Kang E, Tisdalew JF et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol 2000;108:167-75.
34. Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol 2004;125:243-52.
35. Draptchinskaia N, Gustavsson P, Andersson B et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999;21:169-75.
36. Willig T-N, Dratchinskaia N, Dianzani I et al. Mutations in ribosomal protein S19 and Diamond Blackfan anemia: wide variations in phenotypic expression. Blood 1999;94:4294-306.
37. Liu JM, Ellis SR. Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood 2006;107:4583-8.